文献速递主动脉疾病

Zenith支架腔内修复腹主动脉瘤后晚期移植物失败罕见

Late graft failure is rare after endovascular aneurysm repair using the Zenith stent graft in a cohort of high-risk patients.
PubMed 文献 · J Vasc Surg · 2019-05-27

本研究回顾性分析1998至2005年间325例高危患者使用Zenith支架行择期EVAR的15年单中心经验。中位随访5.6年期间,晚期移植物失败发生率为6%,动脉瘤相关死亡率为2%,Kaplan-Meier估计15年免于动脉瘤相关死亡为97%。

要点

  • 高危患者使用Zenith支架行EVAR后晚期移植物失败与动脉瘤相关死亡均少见。
  • 肾功能受损(肌酐≥2 mg/dL)患者晚期移植物失败比例更高(21% vs 6%,P = .03)。
  • 15年Kaplan-Meier估计免于动脉瘤相关死亡为97%,总体生存仅12%。

核心结论

  • 使用Zenith支架行EVAR后晚期移植物失败和动脉瘤相关死亡罕见,尤其在高危合并症缩短预期寿命的患者中。

研究设计与样本

  • 回顾性分析1998年10月至2005年12月在医师发起的IDE下接受Zenith支架择期EVAR的325例高危患者,复习病历与死亡登记。
  • 晚期移植物失败定义为术后>30天发生的I型或III型内漏、瘤囊增大需修正、分支扭结或闭塞、移植物感染、肾动脉闭塞或动脉瘤破裂。

主要发现

  • 中位随访5.6年(四分位距2.6-8.7年)期间发生19例(6%)晚期移植物失败,中位发生时间4.0年(范围39天-14.6年)。
  • 发生6例(2%)动脉瘤相关死亡:1例移植物感染、1例肢体闭塞后股-股旁路感染、1例治疗IB型内漏的移植物感染、3例动脉瘤破裂。
  • 晚期移植物失败患者肾功能受损(肌酐≥2 mg/dL)比例更高(21% vs 6%;P = .03),心脏病比例更低(42% vs 67%;P = .04)。
  • 晚期移植物失败与年龄、性别、动脉瘤大小、支架直径、糖尿病、吸烟或肺部疾病无显著关联。
  • Kaplan-Meier估计总体生存5年60%、10年29%、15年12%;免于动脉瘤相关死亡5年98%、10年97%、15年97%。

关键数值与推荐

  • 晚期移植物失败标准包括I型或III型内漏、瘤囊增大需修正、分支扭结或闭塞、移植物感染、肾动脉闭塞或动脉瘤破裂,均需发生在术后>30天。
  • 患者平均年龄75.9 ± 7.4岁,325例中300例(92%)为男性;平均动脉瘤直径60 ± 9 mm,主体支架中位直径28 mm(范围22-32 mm)。

临床怎么用

  • 对高危患者使用Zenith支架行EVAR后,晚期移植物失败与动脉瘤相关死亡风险低,可据此进行长期随访规划。
  • 合并肾功能受损(肌酐≥2 mg/dL)的患者晚期移植物失败风险较高,应加强影像随访监测。

局限性

  • 本研究为单中心回顾性分析,样本为高危患者,结果外推需谨慎。
  • 随访依赖病历与死亡登记,可能存在晚期移植物失败漏报。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Device-specific data on the long-term efficacy of endovascular aneurysm repair (EVAR) are limited by the constant evolution of stent graft design. Whereas some modifications, such as barb-mediated fixation, probably enhance durability, others, such as thin-walled fabric, are of less certain benefit. The purpose of this study was to examine 15 years of a single-center experience of EVAR using the Zenith stent graft (Cook Medical, Bloomington, Ind). METHODS: Retrospective analysis was conducted of 325 high-risk patients who underwent elective EVAR with Zenith stent grafts between October 1998 and December 2005 under a physician-sponsored investigational device exemption. Patients' charts and death registries were reviewed to identify late stent graft failures and causes of death. Late stent graft failures were defined as type I or type III endoleaks; enlarging aneurysm sac requiring revision; and limb kinking or occlusion, stent graft infection, renal artery occlusion, or aneurysm rupture occurring >30 days after the index procedure. RESULTS: The mean age at treatment was 75.9 ± 7.4 years, and 300 of 325 (92%) were men. The mean aneurysm diameter was 60 ± 9 mm, and the median main body stent graft diameter was 28 mm (range, 22-32 mm). During a median follow-up time of 5.6 years (interquartile range, 2.6-8.7 years), there were six (2%) aneurysm-related deaths caused by the following: one stent graft infection, one infection of a femoral-femoral bypass graft placed after limb occlusion, one infection of a stent graft placed to treat a type IB endoleak, and three aneurysm ruptures. There were 19 (6%) late stent graft failures occurring at a median time of 4.0 years (range, 39 days-14.6 years) after the procedure. Patients with late stent graft failure were more likely to have had impaired renal function (creatinine concentration ≥2 mg/dL; 21% vs 6%; P = .03) and less likely to have had cardiac disease (42% vs 67%; P = .04) at the time of the index procedure. There was no significant association between late stent graft failure and age, sex, aneurysm size, stent graft diameter, diabetes, smoking, or lung disease. Kaplan-Meier estimated overall survival was 60% at 5 years, 29% at 10 years, and 12% at 15 years. Kaplan-Meier estimated freedom from aneurysm-related mortality was 98% at 5 years, 97% at 10 years, and 97% at 15 years. CONCLUSIONS: Late-occurring stent graft failures and aneurysm-related death are rare after EVAR using the Zenith stent graft, especially in high-risk patients whose comorbidities diminish life expectancy.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ramirez JL, Schaller MS, Wu B, et al. Late graft failure is rare after endovascular aneurysm repair using the Zenith stent graft in a cohort of high-risk patients. J Vasc Surg. 2019. PMID: 31147125. doi:10.1016/j.jvs.2019.02.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。